Organigram Global Inc Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
FY EPS (est.)
$0.05next fiscal year
Reporting Calendar
| Event | Expected Date |
|---|---|
| Q4 Fiscal 2026 Earnings Release | 17 Dec 2026 |
Monitoring Framework
Key Performance Indicators
Net Revenue Quarterly59.8MTarget: Exceed $350 million for Fiscal 2026
Adjusted EBITDA Quarterly900KTarget: Exceed Fiscal 2025 levels
International Sales Quarterly6.1MTarget: Average quarterly revenue of €25 million from Sanity Group over the next calendar year
Adjusted Gross Margin Quarterly18.4MTarget: Exceed Fiscal 2025 levels
Watch Items
- Operational stabilization in vapes and infused pre-rollsTrigger: Market share erosion or continued high product returnsAction: Audit manufacturing processes, address hardware specifications, and optimize product mix
- Integration of Sanity Group and German market expansionTrigger: Quarterly revenue contribution below the guided €25 million averageAction: Re-evaluate distribution channels, leverage vertical integration, and align supply chain from Moncton
- EU-GMP certification for the Moncton facilityTrigger: Delays in receiving certification beyond the expected timelineAction: Engage regulatory consultants and address compliance gaps identified during audits
Research as of 20 Jun 2026